Cargando…

Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report

BACKGROUND: Kratom is a psychoactive substance that is isolated from the plant Mitragyna speciosa. The leaves can be chewed fresh or dried, smoked, or infused similar to herbal teas. The plant leaves have been used by natives of Southeast Asia for centuries. The substance has been used for its stimu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandhi, Darshan, Ahuja, Kriti, Quade, Alexis, Batts, Kenneth P, Patel, Love
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643221/ https://www.ncbi.nlm.nih.gov/pubmed/33200023 http://dx.doi.org/10.4254/wjh.v12.i10.863

Ejemplares similares

Kratom-Induced Cholestatic Liver Injury Mimicking Anti-Mitochondrial Antibody-Negative Primary Biliary Cholangitis: A Case Report and Review of Literature
por: Aldyab, Mahmoud, et al.
Publicado: (2019)

Kratom-Induced Cholestatic Liver Injury and Its Conservative Management
por: Fernandes, Christopher T., et al.
Publicado: (2019)

Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report
por: Park, Young Joo, et al.
Publicado: (2021)

Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review
por: Smith, Helen T., et al.
Publicado: (2023)

A case of cholestatic hepatitis associated with histologic features of acute cholangitis
por: Takeuchi, Hajime, et al.
Publicado: (2011)

Histologic Characterization of Kratom Use-Associated Liver Injury
por: Riverso, Michael, et al.
Publicado: (2018)

Disseminated histoplasmosis leading to end stage liver failure in immunocompetent patient: case report and review of literature.
por: Gandhi, Darshan, et al.
Publicado: (2021)

Kratom-Associated Mixed Cholestatic-Hepatocellular Liver Injury in a Patient With Long COVID: A case Report
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
por: Al-Dury, Samer, et al.
Publicado: (2018)

Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia
por: Koh, Hong, et al.
Publicado: (2018)

Editorial: The Pharmacology of Kratom and Its Alkaloids
por: Grundmann, Oliver, et al.
Publicado: (2022)

Platelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitis
por: Wang, Zhongfeng, et al.
Publicado: (2018)

The liver steatosis severity and lipid characteristics in primary biliary cholangitis
por: Zhang, Yuan, et al.
Publicado: (2021)

Increased microfilaments in hepatocytes and biliary ductular cells in cholestatic liver diseases.
por: Chung, Kyu-Won, et al.
Publicado: (2002)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Review of X-ray and computed tomography scan findings with a promising role of point of care ultrasound in COVID-19 pandemic
por: Gandhi, Darshan, et al.
Publicado: (2020)

The Harm in Kratom
por: Drago, Joshua Z., et al.
Publicado: (2017)

Subclinical focal Cholangitis mimicking liver metastasis in asymptomatic patients with history of pancreatic Ductal Adenocarcinoma and Biliary tree intervention
por: Horvat, Natally, et al.
Publicado: (2017)

Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?
por: Papamichalis, Panagiotis A., et al.
Publicado: (2021)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Home-based exercise in patients with refractory fatigue associated with primary biliary cholangitis: a protocol for the EXerCise Intervention in cholesTatic LivEr Disease (EXCITED) feasibility trial
por: Freer, Alice, et al.
Publicado: (2021)

Increased red cell width distribution to lymphocyte ratio is a predictor of histologic severity in primary biliary cholangitis
por: Meng, Jing, et al.
Publicado: (2018)

TR score: A noninvasive model to predict histological stages in patients with primary biliary cholangitis
por: Tu, Zhixin, et al.
Publicado: (2023)

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2(-/-) mouse model of sclerosing cholangitis
por: Fuchs, Claudia D., et al.
Publicado: (2023)

Role of biliary tract cytology in the evaluation of extrahepatic cholestatic jaundice
por: Gupta, Mamta, et al.
Publicado: (2013)

The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A Comprehensive Review
por: Leong Bin Abdullah, Mohammad Farris Iman, et al.
Publicado: (2021)

The impact of primary biliary cholangitis on non-alcoholic fatty liver disease
por: Iluz-Freundlich, Daniel, et al.
Publicado: (2020)

Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis
por: Jin, Yujiao, et al.
Publicado: (2023)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Timing of biliary decompression for acute cholangitis
por: Yang, Jian, et al.
Publicado: (2023)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hmvpjbkn0273m4k5hr88eclk02